Younger Women Are Now More At-Risk for Cancer

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Morgan Pressel's 18th annual Morgan & Friends event raised a record $1,022,000 to support the fight against breast cancer.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.
Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
The American Cancer Society has released its latest report on cancer in the United States, revealing both encouraging and concerning trends.
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...